Lutris Pharma Email Formats

Biotechnology Research • Tel Aviv, Tel-Aviv District, Israel • 1-10 Employees

Lutris Pharma Email Formats

Lutris Pharma uses 3 email formats. The most common is {first name} (e.g., john@lutris-pharma.com), used 50% of the time.

Format	Example	Percentage
{first name}	john@lutris-pharma.com	50%
{first name}.{last name}	john.doe@lutris-pharma.com	25%
{first name}_{last name}	john_doe@lutris-pharma.com	25%

Key Contacts at Lutris Pharma

Sumant Ramachandra

Chief Executive Officer And Board Director

Noa Shelach

Ceo

Company overview

Headquarters	Tel Aviv, Tel-Aviv District, Israel
Website	lutris-pharma.com
Employees	1-10
Socials

About Lutris Pharma

Lutris Pharma is a clinical stage biopharmaceutical company focused on improving anti-cancer therapy effectiveness and quality of life for patients who are being treated with EGFR (Epidermal Growth Factor Receptor) inhibitors or with radiation, where dermal toxicity often leads to a reduction of anti-cancer therapy compliance. The company aims to provide novel topical therapies in order to mitigate these side effects. Lutris Pharma’s lead asset, LUT014, a topical B-Raf Inhibitor, is a proprietary, first-in-class, small molecule currently in a phase 2 clinical trial in metastatic colorectal cancer patients with EGFR inhibitor induced acneiform lesions and a phase 1/2 study for the treatment of radiation-induced dermatitis.